$ILAL
International Land Alliance Inc. Stock $ilal

$ilal Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224026653 Filed on July 09, 2024

Income Statement

Concept	2024 Q3	2024 Q1	2023 Q1
Revenue	$1.303M	$5.089M	$240.9K
YoY Change	263.91%	2012.18%
Cost Of Revenue	$390.8K	$183.6K	$3.000K
YoY Change	31.72%	6019.6%
Gross Profit	$912.5K	$4.905M	$237.9K
YoY Change	1384.94%	1961.65%
Gross Profit Margin	70.01%	96.39%	98.75%
Selling, General & Admin	$635.7K	$462.7K	$870.3K
YoY Change	-37.62%	-46.83%	-36.21%
% of Gross Profit	69.67%	9.43%	365.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$51.53K	$29.75K
YoY Change		73.21%	127.1%
% of Gross Profit		1.05%	12.5%
Operating Expenses	$635.7K	$652.1K	$870.3K
YoY Change	-37.62%	-25.07%	-36.21%
Operating Profit	$276.8K	$4.253M	-$632.3K
YoY Change	-128.9%	-772.62%	-53.65%
Interest Expense		$580.3K	-$981.2K
YoY Change		-159.14%	574.52%
% of Operating Profit		13.64%
Other Income/Expense, Net	-$528.4K	-$603.1K	$0.00
YoY Change	-90.18%
Pretax Income		$3.650M	-$1.909M
YoY Change		-291.25%	27.86%
Income Tax
% Of Pretax Income
Net Earnings	-$251.6K	$3.650M	-$27.26M
YoY Change	-96.03%	-113.39%	1726.43%
Net Earnings / Revenue	-19.31%	71.73%	-11315.96%
Basic Earnings Per Share	-$0.01	$0.05	-$0.45
Diluted Earnings Per Share	-$0.01	$0.05	-$0.45
COMMON SHARES
Basic Shares Outstanding	86.76M shares	79.31M shares	60.16M shares
Diluted Shares Outstanding	90.34M shares	79.31M shares	60.16M shares

Balance Sheet

Concept	2024 Q3	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments		$136.9K	$199.4K
YoY Change		-31.36%	3.16%
Cash & Equivalents	$3.339K	$136.9K	$199.4K
Short-Term Investments
Other Short-Term Assets		$16.82K	$8.840K
YoY Change		90.27%	-96.05%
Inventory
Prepaid Expenses
Receivables	$1.297M	$1.506M	$1.673M
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$1.326M	$1.659M	$1.882M
YoY Change	-26.0%	-11.81%	156.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.830M	$1.802M	$3.232M
YoY Change	0.84%	-44.24%	56.13%
Goodwill	$11.12M	$11.12M
YoY Change	-50.28%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$440.0K	$55.77K	$47.64K
YoY Change	773.41%	17.06%	-92.64%
Total Long-Term Assets	$29.17M	$28.76M	$3.279M
YoY Change	14.66%	776.85%	-38.05%
TOTAL ASSETS
Total Short-Term Assets	$1.326M	$1.659M	$1.882M
Total Long-Term Assets	$29.17M	$28.76M	$3.279M
Total Assets	$30.49M	$30.41M	$5.161M
YoY Change	11.98%	489.33%	-14.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$2.293M	$1.687M
YoY Change		35.93%	20.9%
Accrued Expenses		$1.264M	$708.2K
YoY Change		78.49%
Deferred Revenue	$142.9K	$143.4K
YoY Change	53.06%
Short-Term Debt	$500.0K	$651.8K	$17.68M
YoY Change	-94.76%	-96.31%	1834.18%
Long-Term Debt Due		$2.745M	$1.890M
YoY Change		45.24%	-5.82%
Total Short-Term Liabilities	$15.14M	$15.38M	$32.57M
YoY Change	-55.75%	-52.78%	628.75%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities		$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.14M	$15.38M	$32.57M
Total Long-Term Liabilities		$0.00	$0.00
Total Liabilities	$15.14M	$15.38M	$32.57M
YoY Change	-55.75%	-52.78%	628.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$23.70M	-$23.50M
YoY Change	-29.67%
Common Stock	$89.01K	$85.06K
YoY Change	18.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$300.0K	$300.0K
YoY Change	0.0%
Treasury Stock Shares
Shareholders Equity	$14.75M	$14.43M	-$27.41M
YoY Change
Total Liabilities & Shareholders Equity	$30.49M	$30.41M	$5.161M
YoY Change	11.98%	489.33%	-14.36%

Cashflow Statement

Concept	2024 Q3	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$251.6K	$3.650M	-$27.26M
YoY Change	-96.03%	-113.39%	1726.43%
Depreciation, Depletion And Amortization		$51.53K	$29.75K
YoY Change		73.21%	127.1%
Cash From Operating Activities		$191.7K	$36.98K
YoY Change		418.36%	-110.72%
INVESTING ACTIVITIES
Capital Expenditures		$259.9K	$395.0K
YoY Change		-34.21%	-462.36%
Acquisitions
YoY Change
Other Investing Activities			$321.9K
YoY Change
Cash From Investing Activities		-$259.9K	-$73.05K
YoY Change		255.74%	-32.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$64.79K	186.1K
YoY Change		-65.18%	-68.49%
NET CHANGE
Cash From Operating Activities		$191.7K	36.98K
Cash From Investing Activities		-$259.9K	-73.05K
Cash From Financing Activities		$64.79K	186.1K
Net Change In Cash		-$3.392K	150.0K
YoY Change		-102.26%	9.75%
FREE CASH FLOW
Cash From Operating Activities		$191.7K	$36.98K
Capital Expenditures		$259.9K	$395.0K
Free Cash Flow		-$68.18K	-$358.0K
YoY Change		-80.95%	51.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Deferred Income Current DeferredIncomeCurrent		usd
CY2024Q1	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	ILAL	Common Stock Payable CommonStockPayable		usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2024Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2024Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2024Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2024Q1	ILAL	Excess Fair Value Of Derivative Over Carrying Balance Of Debt ExcessFairValueOfDerivativeOverCarryingBalanceOfDebt		usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
CY2024Q1	ILAL	Increase Decrease In Accounts Payable And Accrued Interestrelated Party IncreaseDecreaseInAccountsPayableAndAccruedInterestrelatedParty		usd
CY2024Q1	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition		usd
CY2024Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets		usd
CY2023Q1	ILAL	Common Stock Warrants And Options Sold For Cash CommonStockWarrantsAndOptionsSoldForCash		usd
CY2023Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2024Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024Q1	ILAL	Dividend On Series B DividendOnSeriesB		usd
CY2023Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
CY2023Q1	ILAL	Series A Shares Issued For Conversion Of Related Party Notes Payable SeriesASharesIssuedForConversionOfRelatedPartyNotesPayable		usd
CY2024Q1	ILAL	Debt Discount From Issuance Of New Promissory Notes DebtDiscountFromIssuanceOfNewPromissoryNotes		usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent		usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent		usd
CY2024Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2024Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent		usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2024Q1	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q1	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2024Q1	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermExercised
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
CY2024Q1	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2024Q1	us-gaap	Cash Cash	136856	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1505712	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16815	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	1659383	usd
CY2024Q1	us-gaap	Land Land	15776526	usd
CY2024Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	1802161	usd
CY2024Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	2677	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	55767	usd
CY2024Q1	us-gaap	Goodwill Goodwill	11118187	usd
CY2024Q1	us-gaap	Assets Assets	30414701	usd
CY2023Q4	us-gaap	Deferred Income Current DeferredIncomeCurrent	4521222	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	143382	usd
CY2024Q1	us-gaap	Deposits Deposits	20500	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	804672	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	620074	usd
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	8900000	usd
CY2024Q1	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	7436657	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	15380153	usd
CY2024Q1	us-gaap	Liabilities Liabilities	15380153	usd
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	603500	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	85064195	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82064195	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79658165	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76658165	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	85064	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	38190434	usd
CY2023Q4	ILAL	Common Stock Payable CommonStockPayable	31939	usd
CY2024Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3000000	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3000000	shares
CY2024Q1	us-gaap	Treasury Stock Value TreasuryStockValue	300000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23544588	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	14431048	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30414701	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5088874	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	183588	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	3001	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	4905286	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	237931	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	167689	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	260084	usd
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	189369	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	245674	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	295001	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	610180	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	652059	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1115938	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	4253228	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-878007	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-49329	usd
CY2024Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-22748	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-397678	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	580329	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	583547	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-603077	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1030554	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	3650150	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1908561	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	25354976	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3650150	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-27263537	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.45
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.45
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79308430	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79308430	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	60159088	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	60159088	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1093530	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	3026	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	78047	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100919	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	49126	usd
CY2024Q1	ILAL	Stock Issued During Period Value Issued For Conversion Of Related Party Debt StockIssuedDuringPeriodValueIssuedForConversionOfRelatedPartyDebt	9456250	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	3650150	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	14431048	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4844482	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-4844482	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1800000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket	2674976	usd
CY2023Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	25354972	usd
CY2023Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	300000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	147805	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	15000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	-15000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1908561	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-27707187	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-27707187	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	3650150	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1908561	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	213931	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	78047	usd
CY2024Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	189369	usd
CY2023Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	245674	usd
CY2023Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	15000	usd
CY2023Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-49329	usd
CY2024Q1	us-gaap	Depreciation Depreciation	51531	usd
CY2023Q1	us-gaap	Depreciation Depreciation	29748	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	160830	usd
CY2023Q1	ILAL	Excess Fair Value Of Derivative Over Carrying Balance Of Debt ExcessFairValueOfDerivativeOverCarryingBalanceOfDebt	36062	usd
CY2024Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-22748	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-397678	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-146374	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-31280	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-40363	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	282543	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	5070	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	608001	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-15754	usd
CY2023Q1	ILAL	Increase Decrease In Accounts Payable And Accrued Interestrelated Party IncreaseDecreaseInAccountsPayableAndAccruedInterestrelatedParty	154462	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-4521222	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	303713	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-63348	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-294346	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	50000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	129830	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	191688	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	36978	usd
CY2023Q1	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	321919	usd
CY2024Q1	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	259867	usd
CY2023Q1	us-gaap	Payments To Acquire Land Held For Use PaymentsToAcquireLandHeldForUse	215266	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	179700	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-259867	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-73047	usd
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	51267	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	100850	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	5000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	63058	usd
CY2024Q1	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	32003	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	100000	usd
CY2024Q1	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	78058	usd
CY2023Q1	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	23776	usd
CY2024Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	75000	usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	226220	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	64788	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	186088	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3392	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	150019	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	140247	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	49374	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	136856	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	199393	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	13456	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	47285	usd
CY2023Q1	ILAL	Dividend On Series B DividendOnSeriesB	15000	usd
CY2024Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	49126	usd
CY2024Q1	ILAL	Series A Shares Issued For Conversion Of Related Party Notes Payable SeriesASharesIssuedForConversionOfRelatedPartyNotesPayable	9456250	usd
CY2023Q1	ILAL	Debt Discount From Issuance Of New Promissory Notes DebtDiscountFromIssuanceOfNewPromissoryNotes	104250	usd
CY2024Q1	ILAL	Common Shares Issued For Services CommonSharesIssuedForServices	213931	usd
CY2023Q1	ILAL	Common Shares Issued For Services CommonSharesIssuedForServices	15000	usd
CY2024Q1	ILAL	Working Capital WorkingCapital	13700000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	3650000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23500000	usd
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p id="xdx_84B_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zVk0mIr2Eelc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zg15vbe8G5Be">Reclassification</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain numbers from 2023 have been reclassified to conform with the current year presentation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_z7nsX3o8RRh9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_znKF5b2Tiqx">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management regularly evaluates estimates and assumptions related to the valuation of assets and liabilities. Management bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from management’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Liability for legal contingencies.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Useful life of buildings.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assumptions used in valuing equity instruments.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes and related valuation allowances.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Going concern.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assessment of long-lived assets for impairment.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant influence or control over the Company’s investee.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">■</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue recognition.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	804672	usd
CY2024Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	804672	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	781924	usd
CY2024Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-22748	usd
CY2024Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	804672	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5088874	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	240932	usd
CY2024Q1	us-gaap	Advertising Expense AdvertisingExpense	167589	usd
CY2023Q1	us-gaap	Advertising Expense AdvertisingExpense	260084	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	44107500	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	42867500	shares
CY2024Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_z0nPzD7fAVBc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_z75O82SSPu7j">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank and financial institution deposits that at times may exceed federally insured limits. The Company has not experienced any losses in such accounts through March 31, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	0	usd
CY2024Q1	ILAL	Unpaid Amount Owed UnpaidAmountOwed	58560	usd
CY2023Q4	ILAL	Unpaid Amount Owed UnpaidAmountOwed	58560	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	824127	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	772596	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1802161	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1818825	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	51531	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29748	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Property Held For Sale ProceedsFromSaleOfPropertyHeldForSale	1500000	usd
CY2024Q1	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	500000	usd
CY2024Q1	ILAL	Notes Payable Gross NotesPayableGross	2744762	usd
CY2023Q4	ILAL	Notes Payable Gross NotesPayableGross	2674762	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	2744762	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	2674762	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	2744762	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2674762	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	651811	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	9585111	usd
CY2024Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	31737	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	33034	usd
CY2024Q1	us-gaap	Convertible Debt ConvertibleDebt	620074	usd
CY2023Q4	us-gaap	Convertible Debt ConvertibleDebt	9552077	usd
CY2024Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	620074	usd
CY2023Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	9552077	usd
CY2023Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	2680000	usd
CY2022Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	0	usd
CY2023	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1090617	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1516622	usd
CY2023	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-1110022	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-926798	usd
CY2024Q1	ILAL	Net Budget NetBudget	1556000	usd
CY2023Q4	ILAL	Net Budget NetBudget	1556000	usd
CY2024Q1	ILAL	Net Budget Inclusive Of Lots Construction NetBudgetInclusiveOfLotsConstruction	995747	usd
CY2023Q4	ILAL	Net Budget Inclusive Of Lots Construction NetBudgetInclusiveOfLotsConstruction	995747	usd
CY2024Q1	us-gaap	Other Commitment OtherCommitment	560250	usd
CY2023Q4	us-gaap	Other Commitment OtherCommitment	560250	usd
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2010000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	85064195	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82064195	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	79658165	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	76658165	shares
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	293500	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	38107500	shares
CY2023Q4	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.16
CY2023	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning	P4Y2M1D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	38107500	shares
CY2024Q1	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	0.16
CY2024Q1	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermEnding	P3Y8M1D
CY2024Q1	ILAL	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	38107500	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6000000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.34
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y1M20D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	6000000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.34
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y7M20D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	6000000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd

Files In Submission

Name	View Source	Status
0001493152-24-026653-index-headers.html	Edgar Link	pending
0001493152-24-026653-index.html	Edgar Link	pending
0001493152-24-026653.txt	Edgar Link	pending
0001493152-24-026653-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
ilal-20240331.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ilal-20240331_cal.xml	Edgar Link	unprocessable
ilal-20240331_def.xml	Edgar Link	unprocessable
ilal-20240331_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
ilal-20240331_pre.xml	Edgar Link	unprocessable
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ILAL
International Land Alliance Inc. Stock $ilal

2024 Q3 Form 10-Q Financial Statement

#000149315224026653 Filed on July 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ILAL International Land Alliance Inc. Stock $ilal

2024 Q3 Form 10-Q Financial Statement

#000149315224026653 Filed on July 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ILAL
International Land Alliance Inc. Stock $ilal